Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus. 1972

B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females

Related Publications

B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
March 1958, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
January 1976, Acta medica Academiae Scientiarum Hungaricae,
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
January 1990, The American journal of medicine,
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
December 1988, Lancet (London, England),
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
July 1975, American journal of diseases of children (1960),
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
April 1980, Science (New York, N.Y.),
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
January 1963, Experientia,
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
December 1979, Lancet (London, England),
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
June 1987, Annals of the rheumatic diseases,
B H Hahn, and G C Sharp, and W S Irvin, and O S Kantor, and C A Gardner, and M K Bagby, and H M Perry, and C K Osterland
April 2020, Lupus,
Copied contents to your clipboard!